Results of coronavirus vaccine trials call for cautious optimism
Never before have candidate vaccines been developed from scratch, tested on animals and completed early stages of human clinical
Read MoreNever before have candidate vaccines been developed from scratch, tested on animals and completed early stages of human clinical
Read MoreThe case fatality rate in India, which has been falling steadily, has for the first time dipped below the
Read MorePhase-2 trial using a single dose of recombinant adenovirus vaccine (Ad5-nCoV) vector carries the genetic material that codes for spike
Read MoreThe preliminary results of the Phase-1/2 clinical trial of the Oxford vaccine shows the vaccine is safe, well-tolerated, and immunogenic.
Read MoreWith surveillance not being commendable, the 10.3% test positivity rate nationally in the last few days is a clear indication
Read MoreModerna’s candidate mRNA vaccine for novel coronavirus has no safety issues and is able to elicit immune responses in all
Read MoreA low-cost, probe-free RT-PCR COVID-19 detection assay developed by IIT Delhi will be launched tomorrow (July 15). The assay
Read MoreResearchers from the Faridabad-based Translational Health Science and Technology Institute (THSTI) have developed an Aptamer-based assay for novel coronavirus
Read MoreWhen COVID-19 deaths in the U.S. stood at 56,246 on April 25, it is been estimated that 30,755 excess
Read MoreAt least five studies found people unexposed to novel coronavirus exhibiting T cell immune responses specific to SARS-CoV-2. This
Read MoreThe study found a few patients exhaled coronavirus into the air at an estimated rate of 1000-1,00,000 RNA copies/minute.
Read MoreThe World Health Organization on July 9 acknowledged that novel coronavirus can be airborne in closed settings and spread
Read MoreThe capricious decision to withdraw from WHO will have dire consequences for global public health. The departure of the
Read More